Find out if you have a Bextra® side effects claim
A settlement with Pfizer, the manufacturer of Celebrex and Bextra, and our Celebrex and Bextra clients has been reached. As a result, we are no longer accepting new Celebrex or Bextra claims.
Concerns for cardiovascular related Bextra® side effects have been raised in the media again following new reports on the dangers of the Cox-2 Inhibitor family of drugs. On February 16, 2005, the FDA’s panel to evaluate the safety of these drugs featured testimony from Merck & Co. who told FDA advisers that research linking its withdrawn Vioxx to heart attacks and strokes may apply to the entire class of painkillers, including Celebrex® and Bextra®.
Bextra News from the New York Times, November 22, 2004
Washington – At a hearing Thursday on Capitol Hill, senators excoriated top federal drug regulators for failing to realize three years ago that Vioxx®, a pain pill that Merck withdrew in September, was dangerous. But the Food and Drug Administration today faces almost exactly the same situation with another arthritis drug, Bextra®, that it did with Vioxx® three years ago. And just as with Vioxx®, it is far from clear what the agency should do. Read more of the story
According to a study conducted by cardiologist Dr. Garrett Fitzgerald of the University of Pennsylvania, the incidence of heart attacks and strokes among patients given Bextra® is two times that of patients taking placebo. Fitzgerald’s study pooled data from 5,930 patients taking part in 12 trials.
As the article and Dr. Garrett Fitzgerald suggest, Bextra® users may have an increased risk for serious cardiovascular side effects including strokes, heart attacks, heart failure, blood clots and even death. Like the recently recalled drug Vioxx, Bextra® is a member of the COX-2 inhibitor family and shares some of the criticisms that forced Merck to withdraw Vioxx® from the market on September 30, 2004.
Bextra® (valdecoxib) has been sold since 2002 and is marketed by Pfizer and Pharmacia for the treatment of pain and tenderness associated with osteoarthritis and adult rheumatoid arthritis.
Bextra® has been further associated with skin hypersensitivity disorders and Stevens Johnson Syndrome, an acute allergic reaction. Symptoms of such adverse reactions include blistering, sores, swelling, cough, and fever.